153 related articles for article (PubMed ID: 28230660)
1. Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
Ueda K; Kawabe K; Lee L; Tachibana Y; Fujimori N; Igarashi H; Oda Y; Jensen RT; Takayanagi R; Ito T
Pancreas; 2017 Apr; 46(4):476-481. PubMed ID: 28230660
[TBL] [Abstract][Full Text] [Related]
2. Insulin surrogates in insulinoma.
O'Brien T; O'Brien PC; Service FJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):448-51. PubMed ID: 8345050
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test.
Li X; Zhang F; Chen H; Yu H; Zhou J; Li M; Li Q; Li L; Yin J; Liu F; Bao Y; Han J; Jia W
Endocr J; 2017 Jan; 64(1):49-57. PubMed ID: 27725372
[TBL] [Abstract][Full Text] [Related]
4. [Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests].
Gorini M; Ghizzi A; Carlo Stella C; De Caro L
Minerva Med; 1985 Sep; 76(37):1663-75. PubMed ID: 2995870
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.
Nauck MA; Meier JJ
Ann Intern Med; 2012 Dec; 157(11):767-75. PubMed ID: 23208166
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation in insulinoma predicts histopathological tumour characteristics.
Wolf P; Winhofer Y; Smajis S; Anderwald CH; Scheuba C; Niederle B; Gessl A; Luger A; Krebs M; Koperek O
Clin Endocrinol (Oxf); 2015 Jul; 83(1):67-71. PubMed ID: 25817061
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma β-hydroxybutyrate levels during the fasting test in patients with endogenous hyperinsulinaemic hypoglycaemia.
Buffet A; Vezzosi D; Maiza JC; Grunenwald S; Bennet A; Caron P
Eur J Endocrinol; 2013 Jul; 169(1):91-7. PubMed ID: 23657581
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma.
van Bon AC; Benhadi N; Endert E; Fliers E; Wiersinga WM
Neth J Med; 2009; 67(7):274-8. PubMed ID: 19687521
[TBL] [Abstract][Full Text] [Related]
9. Using the Secretion Ratios of Insulin and C-peptide During the 2-h Oral Glucose Tolerance Test to Diagnose Insulinoma.
Liao J; Ding F; Luo W; Nie X; He Y; Li G
Dig Dis Sci; 2021 May; 66(5):1533-1539. PubMed ID: 32529519
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the diagnostic accuracy of the current guidelines for detecting insulinoma.
Dauben L; Simon MC; Strassburger K; Burkart V; Weber KS; Schinner S; Roden M; Müssig K
Eur J Endocrinol; 2019 Jun; 180(6):381-386. PubMed ID: 30991361
[TBL] [Abstract][Full Text] [Related]
11. The role of proinsulin and insulin in the diagnosis of insulinoma: a critical evaluation of the Endocrine Society clinical practice guideline.
Guettier JM; Lungu A; Goodling A; Cochran C; Gorden P
J Clin Endocrinol Metab; 2013 Dec; 98(12):4752-8. PubMed ID: 24081736
[TBL] [Abstract][Full Text] [Related]
12. Case report: a glucose responsive insulinoma--implication for the diagnosis of insulin secreting tumors.
Sjoberg RJ; Kidd GS
Am J Med Sci; 1992 Sep; 304(3):164-7. PubMed ID: 1476155
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients.
Nauck M; Stöckmann F; Creutzfeldt W
Eur J Clin Invest; 1990 Feb; 20(1):15-28. PubMed ID: 1969348
[TBL] [Abstract][Full Text] [Related]
14. Insulinoma in a patient with normal results from prolonged fast and glucagon-induced hypoglycemia.
Soh AW; Kek PC
Endocr Pract; 2010; 16(5):838-41. PubMed ID: 20570814
[TBL] [Abstract][Full Text] [Related]
15. Accurate localization of insulinoma using percutaneous transhepatic portal venous sampling--usefulness of simultaneous measurement of plasma insulin and glucagon levels.
Kinoshita Y; Nonaka H; Suzuki S; Kondo T; Chihara K; Chiba T; Fujita T; Kotoura Y; Yamamura T
Clin Endocrinol (Oxf); 1985 Nov; 23(5):587-93. PubMed ID: 3002671
[TBL] [Abstract][Full Text] [Related]
16. Forty-eight-hour fast: the diagnostic test for insulinoma.
Hirshberg B; Livi A; Bartlett DL; Libutti SK; Alexander HR; Doppman JL; Skarulis MC; Gorden P
J Clin Endocrinol Metab; 2000 Sep; 85(9):3222-6. PubMed ID: 10999812
[TBL] [Abstract][Full Text] [Related]
17. Homeostasis Model Assessment of β-Cell Function for Diagnosis of Insulinoma.
Bódis K; Schön M; Dauben L; Wilker M; Strassburger K; Burkart V; Roden M; Müssig K
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1125-e1132. PubMed ID: 37888878
[TBL] [Abstract][Full Text] [Related]
18. Concurrent insulinoma and impaired glucose tolerance suspected as owing to obesity.
Iizuka K; Fujisawa T; Takeda J
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26729835
[TBL] [Abstract][Full Text] [Related]
19. [Missed hyperinsulinaemia in a patient with an insulinoma].
Wouters RS; van den Ouweland JM; Pouwels JG; Wolffenbuttel BH
Ned Tijdschr Geneeskd; 2005 Apr; 149(17):944-6. PubMed ID: 15884409
[TBL] [Abstract][Full Text] [Related]
20. Insulinoma.
Halder PJ; Hafeezunnisa P; Pai R; Samsi AB
J Postgrad Med; 1992; 38(4):202-4, 198. PubMed ID: 1307597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
